Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0YMRIE
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
JSKN016
|
|||||
| Synonyms |
JSKN-016; JSKN 016; JSKN016
Click to Show/Hide
|
|||||
| Organization |
Suzhou Alphamab Co. Ltd.
|
|||||
| Drug Status |
Phase 2
|
|||||
| Indication |
In total 2 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-3 (HER3); Tumor-associated calcium signal transducer 2 (TROP2)
|
Antigen Info | ||||
| Payload Name |
DNA topoisomerase-I inhibitor
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
